Impact of relative dose intensity (RDI) in CHOP combined with rituximab (R-CHOP) on survival in diffuse large B-cell lymphoma

BACKGROUND: Recently, maintaining higher relative dose intensity (RDI) of chemotherapeutic drugs has become a widespread practice in an attempt to achieve better outcomes in the treatment of aggressive lymphoma. The addition of rituximab to chemotherapy regimens has significantly improved outcome in...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Terada, Yoshiki, Nakamae, Hirohisa, Aimoto, Ran, Kanashima, Hiroshi, Sakamoto, Erina, Aimoto, Mizuki, Inoue, Eri, Koh, Hideo, Nakane, Takahiko, Takeoka, Yasunobu, Ohsawa, Masahiko, Koh, Ki-Ryang, Yamane, Takahisa, Nakao, Yoshitaka, Ohta, Kensuke, Mugitani, Atsuko, Teshima, Hirofumi, Hino, Masayuki
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2009
Fag:
Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2743657/
https://ncbi.nlm.nih.gov/pubmed/19689822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-28-116
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker